Latest News about APLS
Recent news which mentions APLS
From InvestorPlace
Apellis Pharmaceuticals' Pegcetacoplan Meets Primary Goal In Late-Stage Study In Patients With Rare Kidney Diseases
August 08, 2024
From Benzinga
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
August 02, 2024
Tickers
APLS
From Benzinga
From Benzinga
Tickers
APLS
From InvestorPlace
From Benzinga
From Benzinga
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
March 27, 2024
Tickers
APLS
From Benzinga
Peering Into Apellis Pharmaceuticals's Recent Short Interest
March 15, 2024
Tickers
APLS
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
From Benzinga
Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years
February 22, 2024
From Benzinga
$1000 Invested In Apellis Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
February 05, 2024
From Benzinga
From Benzinga
Critical Insights From Apellis Pharmaceuticals Analyst Ratings: What You Need To Know
January 30, 2024
Tickers
APLS
From Benzinga
From Benzinga
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 15, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
December 25, 2023
From Benzinga
Karuna Therapeutics Jumps Following Takeover By Bristol Myers, Joins Rocket Lab USA, Altair Engineering And Other Big Stocks Moving Higher On Friday
December 22, 2023
From Benzinga
Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?
December 21, 2023
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
